Shareholder Equity |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Shareholder Equity | |
| Shareholder Equity | Note 9 - Shareholder Equity
Pharmaceutical Resource Technology, Inc.is authorized to issue 3,000,000,000 shares of common stock with a par value of $0.01 per share. As of June 30, 2026, the Company had 2,854,462,696 shares of common stock issued and outstanding.
Common stock is recorded at par value, with amounts received in excess of par value recorded as additional paid -in capital. The Company has not issued any preferred stock as of June 30, 2026.
Accumulated deficit represents cumulative net losses and gains since inception. For the periods ended June 30, 2025 and 2026, the Company reported net gain of $880,244 and net loss $322,177, respectively, which increased the accumulated deficit.
All shares issued during the periods presented were fully paid and non-assessable. The Company did not declare or pay dividends during the periods ended June 30, 2025 and 2026. |